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ABSTRACT
Objective To test the effectiveness of a complex
intervention designed, within a theoretical framework, to
improve outcomes for patients with coronary heart
disease.
Design Cluster randomised controlled multicentre trial.
Setting General practices in Northern Ireland and the
Republic of Ireland, regions with different healthcare
systems.
Participants903patientswithestablishedcoronaryheart
disease registered with one of 48 practices.
Intervention Tailored care plans for practices (practice
based training in prescribing and behaviour change,
administrative support, quarterly newsletter), and
tailored care plans for patients (motivational
interviewing, goal identification, and target setting for
lifestyle change) with reviews every four months at the
practices. Control practices provided usual care.
Main outcome measures The proportion of patients at
18monthfollow-upabovetargetlevelsforbloodpressure
and total cholesterol concentration, and those admitted
to hospital, and changes in physical and mental health
status (SF-12).
ResultsAtbaselinethenumbers(proportions)ofpatients
above the recommended limits were: systolic blood
pressuregreaterthan140mmHg(305/899;33.9%,95%
confidence interval 30.8% to 33.9%), diastolic blood
pressuregreaterthan90mmHg(111/901;12.3%,10.2%
to 14.5%), and total cholesterol concentration greater
than5mmol/l(188/860;20.8%,19.1%to24.6%).Atthe
18 month follow-up there were no significant differences
between intervention and control groups in the numbers
(proportions) of patients above the recommended limits:
systolic blood pressure, intervention 98/360 (27.2%) v
control, 133/405 (32.8%), odds ratio 1.51 (95%
confidenceinterval0.99to2.30;P=0.06);diastolicblood
pressure, intervention 32/360 (8.9%) v control, 40/405
(9.9%), 1.40(0.75to 2.64; P=0.29);and totalcholesterol
concentration, intervention 52/342 (15.2%) v control,
64/391(16.4%),1.13(0.63to2.03;P=0.65).Thenumber
of patients admitted to hospital over the 18 month study
period significantly decreased in the intervention group
compared with the control group: 107/415 (25.8%) v
148/435 (34.0%), 1.56 (1.53 to 2.60; P=0.03).
Conclusions Admissions to hospital were significantly
reduced after an intensive 18 month intervention to
improve outcomes for patients with coronary heart
disease, but no other clinical benefits were shown,
possibly because of a ceiling effect related to improved
management of the disease.
Trial registration Current Controlled Trials
ISRCTN24081411.
INTRODUCTION
Despite the substantial potential to reduce the risk of
recurrentdiseaseanddeathamongpatientswithestab-
lished coronary heart disease, initial reports on the
implementation of prevention guidelines were
disappointing.
1 Systematic reviews of structured man-
agement programmes among these patients have,
however, confirmed that such programmes improve
both processes of care and clinical outcomes.
2
Clarification of the optimal mix of components and
provision of enhanced details of complex health ser-
vice interventions are important.
34 Many trials have
been characterised by important limitations such as
short follow-up, limited generalisability to primary
care, and poor descriptions of interventions.
3 A need
for a phased and careful approach to the development
of complex interventions and an emphasis on explicit
theoreticalfoundationshasbeenhighlighted.
4McAlis-
terandMoher
35showedthatdiseasemanagementpro-
grammes may not achieve expected returns when
baseline management levels are high. In the presence
of current fast changing environments, regarding both
population changes and disease management pro-
grammes, it is even more important that the potential
contributions of disease management programmes
continue to be evaluated in controlled trials. Without
suchcontrolstheimpactofspecificinterventionscould
be overestimated. This is particularly pertinent today
as whole health systems move to comprehensive dis-
easemanagementprogrammes,suchasthequalityand
outcomes framework in the United Kingdom.
6
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of an intervention developed for patients with estab-
lishedcoronaryheartdiseaseanddesignedtoimprove
clinicaloutcomesingeneralpractice.Theintervention
was developed according to the Medical Research
Council framework,
7 based on explicit theoretical fra-
meworks, and the trial was done within the context of
an increasing awarenessof the importance of reducing
cardiovascular risk in these patients.
METHODS
Thetrialmethodshavebeenreportedpreviously.
8We
recruited general practices from two different health-
care systems in Ireland (box 1). The Republic of Ire-
land has a mixed healthcare system and Northern
Ireland is served by the UK National Health Service.
Anindividualindependentoftheresearchteamran-
domly selected practices in each of three geographical
areas(basedaroundthreemanagementcentres:Belfast
in Northern Ireland, and Dublin and Galway in the
Republic of Ireland) using computer generated ran-
dom numbers (www.random.org). The practices were
telephoned to confirm their eligibility and to deter-
mine their interest in participating. Practices were eli-
gible if they had a practice nurse involved in general
patient care, had not participated in the pilot, had a
prespecified minimum list size, and were not partici-
pating in Heartwatch (a programme of secondary pre-
ventionofcardiacdiseaseinvolving20%ofpracticesin
the Republic of Ireland).
9 If a practice declined to par-
ticipate, another was selected and invited in the same
way until 16 in each centre had been recruited.
Participating practices prepared lists of all their
patientswithestablishedcoronaryheartdisease:docu-
mented myocardial infarction, coronary artery bypass
grafting,angioplasty,orangina(confirmedbyexercise
stress test, isotope test, or coronary angiogram). We
excluded those with major mental or physical illness
that was likely to impair their capacity to change life-
style behaviour or assimilate new information. Poten-
tial participants from each practice were randomly
selected (www.random.org) at a remote site and sent
an invitation to participate, a reply slip, and question-
nairesrelatingtophysicalandmentalhealthstatus(SF-
12) and lifestyle (validated questionnaires for diet and
exercise).Weallowedsixweeksfornon-response,dur-
ing which time reminders were posted. Patients were
invitedinsequencefromlistsinrandomorder,until20
in each practice had agreed to participate.
Those who consented attended a baseline consulta-
tion at their own practice, where the practice nurse
measured their blood pressure (automated validated
sphygmomanometer, Omron M7, Kyoto, Japan),
waist to hip ratio, and body mass index; took a venous
blood sample for serum cholesterol assay (non-fast-
ing); and recorded prescribed drugs. Cholesterol
assays were done in one of 15 local hospital labora-
tories, all of which participated in an external quality
assurance scheme: either the UK National External
Quality Assurance Service (www.ukneqas.org.uk),
Welsh Quality Assurance Service (www.weqas.com),
or both.
To minimisepotential recruitment bias we collected
baseline data before randomisation of practices to
intervention and control groups. We chose a cluster
randomisation design because our intervention
aimed to alter practitioners’ behaviour and this could
contaminate their interactions with control patients.
Box 1 Key features of healthcare systems in Northern Ireland and Republic of Ireland
Northern Ireland
Publicly funded (NHS)
No charges for access to primary care or hospital care
People are registered for primary care in a specified general practice; the practices are
computerised and receive financial incentives for using disease registers and monitoring
quality of care
Prescriptions are free to those who meet certain criteria, such as low income; others are
asked to pay a nominal fee
Republic of Ireland
Mixed public and private funding
Primary health care is free through the General Medical Services scheme only to those
judged less able to pay or, during theduration of this study, to those aged over 70 (32% of
population registered in 2005)
Registration with a practice is required only if the patient belongs to the General Medical
Services scheme; practices have limited use of computers, few disease registers, and no
specific financial incentives for operating a recall system to monitor patients’ care
Free prescriptions are available only within the General Medical Services scheme; others
pay the full costs of medicines up to a monthly limit (€90 (£84; $134) per family in 2005)
Table 1 |Characteristics of practices and patients at baseline.
Values are numbers (percentages) unless stated otherwise
Characteristics Intervention Control
Practice factors
No of practices 24 24
Practice size:
<2 whole time equivalents 9 (47) 10 (53)
≥2 whole time equivalents 15 (52) 14 (48)
Region:
Northern Ireland 8 (33) 8 (33)
Republic of Ireland 16 (67) 16 (67)
Patient factors
No of patients 444 459
Mean (SD) age (years) 68.5 (9.3) 66.5 (9.9)
Men 311 (70) 320 (70)
Mean(SD)yearssince diagnosisof
coronary heart disease
8.3 (6.6) 8.2 (6.5)
Myocardial infarction 220 (50) 233 (51)
Angina 390 (88) 414 (90)
Diabetes 78 (17.6) 82 (17.9)
Coronary artery bypass grafting 114 (25.7) 124 (27.1)
Percutaneous transluminal
coronary angioplasty
126 (28.4) 149 (32.6)
Eligible for General Medical
Services scheme*
234 (82.4) 218 (73.4)
Married 288 (67) 315 (70)
Manual occupation 134 (42) 172 (51)
Completed secondary education 179 (42) 145 (33)
*Republic of Ireland only.
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whole time equivalent general practitioners in each
practice (<2 and ≥2) and randomised using a process
of minimisation within each centre by an individual
independent of the research team. Baseline usual care
for patients with established coronary heart disease
was documented in all practices before randomisation
andreviewedatfollow-up.Wecheckedtheaccuracyof
data entry for a random 5% sample of participants;
accuracy was established for 97.1% of 1344 items
reviewed.
We developed a multifaceted intervention compris-
ing care plans for both the practices and the patients
(box 2).
10 By exploring practitioners’ and patients’
views,inaccordancewiththeMedicalResearchCoun-
cilframework,
7 we determinedthe durationand inten-
sity of training within the practices and the frequency
of patient recall. As documented previously,
12 social
cognitive theory
13 was the main psychological theory
used to develop the training in behaviour change,
design the booklet for intervention patients,
11 and
inform the development of tailored plans for patient
care. According to this theory, building patients’ self
efficacy or self confidence and facilitating patients in
setting goals and making action plans are central to
the optimal management of chronic disease.
Nocontactwasmadewiththecontrolpracticesafter
the collection of baseline data. They continued with
usual care, which in Northern Ireland involved a sys-
tem for annual review of blood pressure, cholesterol
concentration, smoking status, and prescribed drugs,
in accordance with the criteria specified within the
NHS general practitioner contract quality and out-
comes framework for the management of coronary
heart disease. Although practitioners sought to
improve the management for patients who failed to
meet targets related to those criteria, by adjusting
drugs appropriately and giving advice on lifestyle,
thiswasnotwithinastructuredformat.IntheRepublic
ofIrelandusual caremayhaveincludedmonitoringof
riskfactorsandprovidingappropriateadviceanddrug
management when patients sought a repeat prescrip-
tion, but this was not organised in a formal manner.
Care for patients with coronary heart disease in both
healthcare systems was usually opportunistic; none of
the practices provided motivational interviewing on
lifestyle changes or created individually tailored plans
for patients with identified goals relating to targets for
optimalsecondaryprevention.Furtherinformationon
care within the two systems is reported elsewhere.
14
After 18 months we sent questionnaires to the parti-
cipating patients and invited them to attend their prac-
tices for a follow-up consultation with their practice
nurse, who repeated measurements taken at baseline.
Primary categorical outcomes were the proportions of
patients not achieving target levels for blood pressure
Box 2 Implementation of complex intervention (a more detailed description is available
at http://trialsjournal.com/content/6/1/11)
Tailored practice care
Anaction plan for each practicewasagreed withthe practice and regularlyreviewed bythe
study research nurse and practice
The study nurse maintained regular contact with the practices
The practice received a two page study newsletter every four months
Academic detailing
An academic general practitioner (one per centre) made one 90 minute educational
outreach visit to each intervention practice to promote drug prescribing guidelines for
secondary prevention through interactive case based scenarios
A study research nurse (one per centre) delivered another 90 minute session on behaviour
change, which was intended to facilitate reflection on change to patient lifestyle and,
through role play, new techniques to be used by the practice
Tailored patient care
At the first intervention consultation, the patient and practitioner together identified areas
of management that could be improved and the patient was invited to prioritise one
particular aspect of his or her lifestyle for change
Possible ways of achieving targets reflecting optimal management were identified and
action plans individualised so that small, realistic goals for change were agreed
A booklet
11 containing information on all the key risk factors for coronary heart disease
was used by practitioners in discussions on initial target setting and then given to the
patients
Regular consultations
Patients were invited for an appointment with the general practitioner or nurse every four
months; targets and goals for optimal secondary prevention were reviewed at each visit
Table 2 |Comparison of primary categorical outcomes at baseline and follow-up between intervention and control groups while adjusting for clustering,
baseline differences, and prespecified covariates*. Values are percentages (numbers) unless stated otherwise
Variable
Valid No at baseline/
follow-up Baseline Follow-up Intracluster
correlation
coefficient
Odds ratio†
(95% CI)
P
value
Adjust-
ment for
multiple
testing‡
Intervention
group
Control
group
Intervention
group
Control
group
Intervention
group
Control
group
Blood pressure:
Systolic >140 mm Hg 443/360 456/405 34.1 (151) 33.8 (154) 27.2 (98) 32.8 (133) 0.06 1.51(0.99to2.30) 0.06 0.18
Diastolic >90 mm Hg 443/360 458/405 13.3 (59) 11.4 (52) 8.9 (32) 9.9 (40) 0.29 1.40(0.75to2.64) 0.29 0.58
Total cholesterol >5.0 mmol/l 424/342 436/391 21.7 (92) 22.0 (96) 15.2 (52) 16.4 (64) 0.65 1.13(0.63to2.03) 0.65 0.65
Hospital admissions§ 433/415 449/435 24.5 (106) 31.8 (143) 25.8 (107) 34.0 (148) 0.03 1.56(1.53to2.60) 0.03 0.12
*Relevant covariates: age, sex, education, occupation, years since diagnosis, angina, myocardial infarction, coronary artery bypass grafting, percutaneous transluminal coronary angioplasty,
diabetes, region, practice size. Smoking status also considered for all measurements of blood pressure.
†Intervention group compared with control group.
‡See Holm 1979.
21
§Analysis of hospital admissions and practice visits carried out on adjusted end points rather than change over time, owing to different data collection intervals at baseline (12 months) and
follow-up (18 months).
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admitted to hospital. An admission was attributed to
a cardiac cause only if an explicit and acute cardiac
diagnosis was stated as the primary or secondary rea-
son for admission. Primary continuous variables were
changes in physical and mental health status as mea-
sured by the SF-12. Indicators for diet were collected
using the dietary instrument for nutrition education
(DINE) questionnaire
15 and exercise using the Godin
questionnaire.
16 The results of a parallel qualitative
study involving interviews and focus groups with pur-
posefully selected patients and practitioners will be
reported separately.
Sample size calculation
Detailed sample size calculations are described
elsewhere.
8
Cholesterol—Based on an expected baseline propor-
tion of 36% of patients with cholesterol levels greater
than 5.0 mmol/l (J Leahy, personal communication,
2004) we estimated that a sample of 500 patients
would allow detection, with 80% power and an α of
0.05, of an improvement (reduction) in the proportion
of patients with cholesterol levels greater than
5.0 mmol/l by 50% in the intervention group and
20% in the control group. Allowing for a design effect
size of 1.27 (estimated from a previously observed
intracluster correlation coefficient of 0.019
(N Campbell, personal communication, 2001) and
participation of 15 patients per practice) inflated the
sample size requirement to 635 patients recruited
from 42 practices. Allowing for practice attrition of
10% and 30% loss of patients to follow-up indicated
that we needed to recruit 907 patients from 46 prac-
tices. To include equal numbers of practices within
each of the three centres we recruited patients from
48 practices. This total sample size of 907 would
allow the detection of clinically significant differences
in the other primary outcomes with an α of 0.05 and
power greater than 80%.
Blood pressure—Based on previous reports, 44% of
patients were likely to have a baseline systolic blood
pressure greater than 140 mm Hg (J Leahy, personal
communication,2004),andanimprovementof20%in
this proportion was likely in the control group.
17 To
detect a 50% improvement in the proportion of
patients in the intervention group with a systolic
blood pressure greater than 140 mm Hg with 80%
power and an α of 0.05 required a sample of 408
patients. Based on a design effect size of 1.15 (intra-
clustercorrelationcoefficient0.011
17andparticipation
of 15 patients per practice) and allowing for 10% prac-
tice attrition and 30% patient attrition inflated this
requirement to 670 patients from 34 practices.
SF-12—Based on a baseline mean of 53.98 (SD
8.39)
18 for SF-12 physical and mental health status
scores, we estimated that we would require a sample
size of 120 patients to detect a clinically significant
improvement of five points in these scores in the inter-
vention group, with 80% power and an α of 0.05. The
intracluster correlation coefficient from previous
data
18 (<0.001) indicated that there is no clustering
effect for this variable and the design effect size is 0.
To allow for 10% practice attrition and 30% patient
attrition we estimated that a sample of 170 patients
from 10 practices was required.
Hospital admissions—Previous data
19 indicated that
43% of control patients had hospital admissions over
two years. To detect a reduction in this by 50% in the
intervention group and 20% in the control group with
80% power and an α of 0.05 we estimated that we
required a sample size of 356 patients. Based on a
design effect size of 1.08 (intracluster correlation coef-
ficient 0.006 and participation of 15 patients per prac-
tice), indicated that the sample size should be inflated
to 406 patients from 27 practices. We increased the
sample size to 580 patients from 30 practices to allow
for 10% practice attrition and 30% patient attrition.
Assessed for eligibility (649 practices)
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Randomised (n=48)
Excluded (n=601):
  Not meeting inclusion criteria (n=489)
  Refused to participate (n=112)
Allocated to usual care (n=24)
Received usual care (n=24)
  Mean practice size 19.1, range 11–22;
    459 patients
Did not receive allocated intervention (n=0)
Allocated to intervention (n=24)
Received allocated intervention (n=24)
  Mean practice size 18.5, range 8–22;
    444 patients
Did not receive allocated intervention (n=0)
Lost to follow-up (n=0)
Hospital admissions (chart data) 23 patients:
  Died (n=14) 
  Left practice (n=8)
  Nursing home, chart unavailable (n=1)
SF-12 (questionnaire data) 67 patients:
  Died (n=14)
  Too ill to respond (n=4)
  Left practice (n=7)
  Did not respond, no reason given (n=42)
Blood pressure and cholesterol concentration
  (consultation data) 53 patients:
  Died (n=14)
  Too ill to attend (n=4)
  Left practice (n=8)
  Did not attend, no reason given (n=27)
Lost to follow-up (n=0)
Hospital admissions (chart data) 24 patients:
  Died (n=15) 
  Left practice (n=7)
  Consent withdrawn or ill health (n=2)
SF-12 (questionnaire data) 74 patients:
  Died (n=15)
  Too ill to respond (n=13)
  Left practice (n=7)
  Consent withdrawn or ill health (n=2)
  Did not respond, no reason given (n=37)
Blood pressure and cholesterol concentration
  (consultation data) 82 patients:
  Died (n=15)
  Too ill to attend (n=16)
  Left practice (n=7)
  Consent withdrawn or ill health (n=2)
  Too busy to attend (n=2)
  Did not attend, no reason given (n=40)
Analysed (n=24)
Hospital admissions (chart data)
  Mean practice size 18.9, range 11–22;
    454 patients
SF-12 (questionnaire data)
  Mean practice size 16.3, range 9–20;
    392 patients
Blood pressure and cholesterol concentration
  (consultation data)
  Mean practice size 16.9, range 9–21;
    406 patients
Excluded from analysis
  Practices and patients (n=0)
Analysed (n=24)
Hospital admissions (chart data)
  Mean practice size 18.2, range 7–22;
    437 patients
SF-12 (questionnaire data)
  Mean practice size 15.4, range 4–20;
    370 patients
Blood pressure and cholesterol concentration
  (consultation data)
  Mean practice size 15.1, range 7–20;
    362 patients
Excluded from analysis
  Practices and patients (n=0)
Fig 1 | Flow of practices and patients through study
RESEARCH
page 4 of 10 BMJ | ONLINE FIRST | bmj.comStatistical analysis
The statistical analyses are reported according to the
CONSORT guidelines.
20 To account for variability at
baseline we calculated the response variables as the
change from baseline measurements to follow-up.
We analysed hospital admissions at follow-up while
adjusting for baseline values: analysis of change was
not appropriate owing to different intervals for data
collection at baseline (12 months) and follow-up
(18 months). This difference was caused by delays in
recruitment, which resulted in a shift to one follow-up
point at 18 months rather than the intended two at 12
and 24 months.
We used linear mixed effects regression models for
all analyses to control for clustering (where each prac-
tice was incorporated as a random effect), randomisa-
tion stratifiers, and prespecified variables
8 (age, sex,
education, occupation, years since diagnosis, angina,
myocardialinfarction,coronaryarterybypassgrafting,
percutaneous transluminal coronary angioplasty, dia-
betes, region, practice size). For all measurements of
blood pressure we also considered smoking status.
The estimated treatment group effect represents the
difference in mean change from baseline in control
patients compared with intervention patients.
When modelling the categorical response variables,
werecodedeachresponseasabinaryvariabletoreflect
whether the patient had improved or not—that is,
remained unchanged or lacked improvement. For
each binary response we used a generalised linear
mixed model (using the binomial link function) while
incorporating all confounding variables, using the
same approaches as for the continuous responses. We
presentthe resultsforthetreatmenteffectforeach bin-
aryresponseastheestimatedoddsofimprovementfor
the response variable for those receiving the inter-
vention relative to the controls. In addition to using
linear mixed models, we used a clustered permutation
testforeachanalysisasanalternativemethodtoadjust-
ments for any possible cluster effects.
Model checking was carried out using suitable
model diagnostics and residual plots. All analyses
were carried out using R (version 2.9.0) and Minitab
15 (Minitab, Coventry,UK), and adjustedfor multiple
testing.
21
RESULTS
Figure 1 shows the flow of practices and patients
through the study. In total, 489 practices were ineligi-
ble: 255 (52%) had no practice nurse, 40 (8%) had a
small list size, 97 (20%) were participating in Heart-
watch (Republic of Ireland only), and 56 (12%) had
morethanonecriterionforexclusion.Dataweremiss-
ing for 41 (8%) practices. Non-participating practices
were asked why they had declined. The main reasons
given were workload (n=53), staff issues (n=19), not
interestedinthisparticularstudyorresearchingeneral
(n=9), and miscellaneous (for example, involved in
other initiatives, low remuneration) or not stated
(n=31).
Overall, 1795 patients were invited to participate
and 998 respondedpositively (55.6%), with903 subse-
quently attending a baseline consultation. All inter-
vention practices took part in the educational visits
and all practices completed the study. Forty two
patients discontinued the intervention and 23 patients
inthecontrolgroupdefaultedtofollow-up,leaving838
(92.8%) patients who participated in follow-up. Data
were collected between December 2004 and October
2007. Characteristics of the 48 participating practices
and their existing populations were well balanced
(table 1) apart from occupational status and educa-
tional level. These had been prespecified as covariates
in the analysis.
At baseline the proportion of patients above the
recommended limits for blood pressure (140/90 mm
Table 3 |Comparison of continuous outcomes at baseline and follow-up in intervention and control groups while adjusting for clustering, baseline
differences, and prespecified covariates*. Values are means (standard deviations) unless stated otherwise
Variable
Valid No at baseline/
follow-up Baseline Follow-up Intracluster
correlation
coefficient
Mean difference
(95% CI) P value
Interven-
tion group
Control
group
Interven-
tion group
Control
group
Interven-
tion group
Control
group
Systolic blood pressure (mm Hg) 442/360 451/405 136.3 (22.2) 136.8
(21.2)
133.8 (17.0) 137.9
(19.3)
0.057 3.31 (−1.02 to 7.63) 0.13
Diastolic blood pressure (mm Hg) 442/360 451/405 78.4 (11.9) 79.4(11.3) 77.4 (10.1) 78.6(10.4) 0.045 0.17 (−2.16 to 2.51) 0.88
Total cholesterol concentration (mmol/l) 424/342 436/391 4.4 (0.9) 4.3 (0.9) 4.2 (0.9) 4.2 (0.9) 0.062 0.13 (−0.03 to 0.30) 0.11
No of hospital admissions per patient 440/415 452/435 0.3 (0.6)† 0.4 (0.8)† 0.4 (0.7)‡ 0.5 (1.0)‡ 0.017 −0.15(−0.01to−0.29) 0.03
Noofcardiovascularhospitaladmissions§ 425 444 NA NA 0.14 (0.5) 0.23 (0.7) 0.003 −0.11(−0.21to−0.01) 0.04
Noofotherhospitaladmissionsperpatient 425 444 NA NA 0.24 (0.6) 0.32 (0.7) 0.000 −0.06 (−0.16 to 0.04) 0.22
Primary continuous variables:
SF-12 physical component summary 380/311 382/338 39.9 (11.6) 39.2(10.8) 40.5 (11.1) 38.8(11.1) 0.076 −0.78 (−2.58 to 1.03) 0.39
SF-12 mental component summary 380/311 382/338 49.5 (10.5) 48.4(11.1) 49.6 (10.9) 48.9(11.7) 0.054 −0.02 (−2.40 to 2.35) 0.98
NA=not applicable.
*See footnote to table 2 for relevant covariates.
†Over 12 months.
‡Over 18 months.
§Analysis of hospital admissions and practice visits carried out on adjusted end points rather than change over time, owing to different data collection intervals at baseline (12 months) and
follow-up (18 months).
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 5 of 10Hg) and total cholesterol concentration (5 mmol/l)
were: systolic blood pressure 305/899 (33.9%, 95%
confidence interval 30.8% to 33.9%), diastolic blood
pressure111/901(12.3%,10.2%to14.5%),andcholes-
terol concentration 188/860 (20.8%, 19.1% to 24.6%).
Equivalent proportions at follow-up reflected a trend
towards better control for all patients: systolic blood
pressure 231/765 (30.2%, 26.9% to 33.4%), diastolic
bloodpressure72/765(9.4%,7.3%to11.5%),andcho-
lesterol concentration 116/733 (15.8%, 13.2% to
18.5%).
For any of the response variables of interest there
was little evidence of any significant cluster effect
regardless of whether the mixed models or clustered
permutationtestapproachwasused.Asaconsequence
onlythe resultsofthemixedmodelsapproacharepre-
sented.
At baseline, similar proportions of patients in the
control and intervention groups had blood pressure
and cholesterol levels above recommended limits
(table 2). Although the estimated treatment effects for
bloodpressureandcholesterolconcentrationreflected
an improvement in the intervention group for both
continuous and categorical responses, there were no
significant differences between intervention and con-
trol groups at follow-up (tables 2 and 3). Figure 2
shows box plots of the changes in blood pressure, cho-
lesterol concentration, and SF-12 physical and mental
health components.
At baseline, different proportions of the control and
intervention groups had been admitted to hospital in
the previous 12 months (table 2); this was adjusted for
in the analysis. A significant decrease was found in the
interventiongroupforboththeproportionsofpatients
admitted(table 2)andtheactualnumberofadmissions
per patient over 18 months (table 3). Further analysis
showed that the numbers of admissions per patient for
a cardiovascular event were significantly reduced for
the intervention group, whereas there was no differ-
ence in numbers of hospital admissions for other
causes (table 3).
The rates of visits to general practitioners did not
change but rates of visits to the practice nurse in inter-
vention practices significantly increased (table 4). The
average length of consultations with an intervention
practice nurse was 20.5 minutes (range 2-45 minutes).
Lifestyle changes are presented in table 5. Inter-
vention effects were non-significant. A trend for
decreased smoking prevalence was observed in both
intervention and control groups.
DISCUSSION
After 18 months a complex intervention aimed at
improving the outcome for patients with coronary
heart disease resulted in significant reductions in hos-
pital admissions but no significant improvements in
cholesterol concentration or management of blood
pressure or change in mental or physical health status.
Our baseline levels of blood pressure and cholesterol
concentration were lower than in earlier
studies,
517192223 which themselves exhibited general
progressive improvements since the late 1990s. The
lower than anticipated numbers of patients exceeding
target blood pressure and cholesterol levels may,
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Fig 2 | Change in blood pressure, cholesterol concentration,
and SF-12 physical and mental health components
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and patient attrition rates and intracluster correlation
coefficients, have introduced a potential type II error
for these variables.
Adequate power was achieved for hospital admis-
sions, where consistent and significant decreases were
found for the intervention group in the proportions of
patientsadmitted,themeannumberoftotaladmissions,
and the mean number ofhospital admissions for cardio-
vasculareventsperpatient.Themeannumberofcardio-
vascularhospitaladmissionsperpatientwasbalancedby
no significant differences in the number of admissions
forothercauses.Although the differencesin admissions
may be considered small, they do seem to be clinically
significant. The intervention patients were 56% (95%
confidence interval 1.53% to 2.60%) less likely to be
admitted than the control patients and for every 100
patients undergoing the intervention, 15 (95% confi-
dence interval 1 to 29) fewer admissions could be
expected over an 18 month period (table 2). These
results do, however, need to be interpreted cautiously
as a difference in differences analysis was not possible
owing to the change in time for collection of follow-up
data. Adjustment for multiple testing also removed the
finding of a significant reduction in number of hospital
admissions. The need for such adjustment for indepen-
dent outcomes remains controversial.
24-26
Previous systematic reviews
23 of management pro-
grammes for cardiac disease have highlighted their
potential to decrease the number of hospital admis-
sions, and noted that few actually report this outcome.
We are the first to report a significant difference in
cardiovascular admissions. A Cochrane review in this
area
27 is ongoing, but the lack of detail on hospital
admissions, which we report, is still lacking
(B Buckley, personal communication, 2009).
How was this possible decrease in cardiovascular
hospitaladmissionsachievedintheabsenceofchanges
to either physiological or lifestyle variables (tables 2
and 3)? Previous studies have reported that self man-
agement programmes for chronic disease based on
social cognitive theory increased levels of patient self
efficacy andasa result reducedthe utilisationof health
services, including inpatient days
2829 and outpatient
visits.
30 Although we did not measure levels of patient
self efficacy, it is possible that as happened in these
previous studies the intervention improved levels of
self efficacy thereby increasing patients’ confidence
in their ability to manage their illness without access
to health services. Although qualitative work may
informthisdiscussion,thesehypothesesrequiretesting
in future research.
In the Republic of Ireland a recent uncontrolled eva-
luationof a centrally funded initiative involving second-
arycardiacpreventionin20%ofpracticesnationally(the
Heartwatch programme) found significant improve-
mentsinthemanagementofbloodpressureandcholes-
terol concentrations over almost three years.
9 Our data
from control practices, which were not participating in
Heartwatch, suggest that improvements may be occur-
ring through changes in the population
3132 and general
system rather than through specific interventions in
themselves. These changes may, for example, be occur-
ring through increased societal and patient awareness of
appropriate care, enhanced management of incident
cases in hospital, or improved organisation of general
practices inthe managementofchronic disease, particu-
larly in prescribing.
33 One study reported that improve-
ments in the management of cardiovascular disease
preceded the introduction of the new general practi-
tioner contractin the UK, withits quality and outcomes
framework, and the rate of improvement since then has
remained similar.
6
Itmaybethataceilingeffecthasbeenreachedinthe
secondary management of cardiovascular disease in
primary care. Similar ceiling effects have been noted
recently in relation to medical outcomes in patients
with diabetes.
34 The qualitative findings within our
study (M D’Eath, personal communication, 2009)
indicated that some patients found targeted changes
unachievable or that their practitioners judged them
tobeunattainable.Considerationofthisissueisimpor-
tant as significant resources are being given to support
such interventions in the primary care management of
cardiovascular disease and in the management of
chronic disease generally. As resources are finite and
workloads have increased, it may be that the focus of
management programmes in the secondary preven-
tion of cardiac disease in the community should be
on those with additional absolute risk, such as patients
with several morbidities
3536 or those who are more
disadvantaged.
37
Generalisability of the findings
Researchershaverecentlysystematicallyreviewedthe
internal and external validity of cluster randomised
Table 4 |Visiting rates in intervention and control group practices at baseline and follow-up while adjusting for clustering, baseline differences, and
prespecified covariates*. Values are means (standard deviations) unless stated otherwise
Variable
Valid No at baseline/
follow-up Baseline Follow-up Intracluster
correlation
coefficient
Mean difference
(95% CI) P value
Intervention
group
Control
group
Intervention
group
Control
group
Intervention
group
Control
group
Visits to general practitioner† 397/426 434/444 5.5 (3.8) 4.8 (4.2) 8.3 (5.7) 7.6 (6.0) 0.105 0.29 (−0.97 to 1.56) 0.64
Visits to practice nurse† 397/426 434/444 2.1 (2.9) 1.5 (2.2) 4.6 (4.2) 1.8 (2.2) 0.340 3.00 (1.75 to 4.15) 0.00
*See footnote to table 2 for relevant covariates.
†Analysis of hospital admissions and practice visits carried out on adjusted end points rather than change over time, owing to different data collection intervals at baseline (12 months) and
follow-up (18 months).
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38 We consider that the internal validity of the
current trial is likely to be high as we accounted for
clustering in both the sample size calculations and the
analysis, and we protected against identification and
recruitmentbiasforalleligiblepracticepatientsbytim-
ing randomisation after the collection of baseline data.
One study
39 highlighted such timing as the “corner-
stone” of internal validity for individually randomised
trials. Blind assessment of primary outcomes was not,
however,possible,asiscommoninstudiesofthistype.
The high number of ineligible practices largely
reflects the low numbers of practice nurses in the
Republic of Ireland at the time of practice
recruitment.
40 The practice nurse was a necessary and
key component of the intervention, as exemplified by
visiting rates (table 4). Since mid-2000 the availability
of practice nurses in the Republic of Ireland has
increasedrapidly.Withregardtoexternalvalidity,one
study
38 emphasised the consideration of adoption (the
extent to which the settings are representative of a
wider population of settings) and implementation (the
feasibility and acceptability of the intervention to
health providers in clusters). Our 30% recruitment
rate for practices and 0% attrition rate are similar to
the ranges reported previously.
38 The feasibility of
implementation was supported through quality assur-
ance measures during observation of consultations,
which were clearly not blinded. Parallel qualitative
analysis seemed to confirm the acceptability of an
intervention mediated through the practice nurse (M
D’Eath, personal communication, 2009). The success-
ful delivery of the trial simultaneously in two different
health systems is noteworthy and should potentially
increase generalisability. However, we cannot dis-
count the possibility that selection bias might have
favoured “good” practices and “compliant” patients,
with the result that baseline performance was high
with little scope for improvement.
Limitations of the study
Thepossibilityofselectionbiasneedstobeconsidered
for both practices and patients. However, the baseline
performance of participating practices in both North-
ern Ireland and the Republic of Ireland was similar to
regionalnorms.Anypossibleimpactofregionaldiffer-
encesinprovisionofusualcarehasbeenaccountedfor
by recruiting equal numbers of control and inter-
ventionpracticesinNorthernIrelandandtheRepublic
of Ireland. Patient selection bias should have been
minimised both by practice allocation subsequent to
baseline data collection and by the random selection
ofpatients.Thestudymaybeunderpoweredfordeter-
mination of blood pressure and cholesterol outcomes.
Data collection was not blinded as is common in stu-
dies such as this one. Analysis of hospital admissions
mayhavebeenaffectedbythedifferentdatacollection
periods at baseline and follow-up and consideration of
adjustments for multiple testing.
Ourfindingssuggestthat,withinthecurrentcontext,
attemptstoimprovefurthertheprovisionofsecondary
cardiac care may result in lower numbers of cardio-
vascularhospitaladmissionsbutnototherclinicalben-
efits. Further exploration of the value of such
interventions for those with additional risk or who are
lesslikelytobe receivingoptimaltherapymaybe war-
ranted.
The SPHERE study team also includes C Leathem, A Houlihan, M
O’Malley, V Spillane, H Grealish, and P Ryan (research nurses);
Table 5 |Lifestyle secondary variables in intervention and control groups at baseline and follow-up while adjusting for clustering, baseline differences, and
prespecified covariates*. Values are means (standard deviations) unless stated otherwise
Variable
Valid No at baseline/
follow-up Baseline Follow-up Mean difference
(95% CI) P value Intervention Control Intervention Control Intervention Control
Body mass index 437/351 451/399 28.7 (5.2) 28.8 (4.7) 28.4 (5.0) 28.7 (4.8) 0.09 (-0.32 to 0.49) 0.67
Godin† exercise score 256/249 278/278 22.6 (20.7) 18.9 (17.2) 23.9 (23.7) 21.1 (21.7) -1.28 (-7.25 to 4.69) 0.67
DINE questionnaire‡:
Fibre 414/350 436/366 36.5 (12.4) 34.7 (12.1) 33.5 (12.0) 33.5 (13.4) 2.26 (-0.07 to 4.59) 0.06
Fat 390/330 415/343 31.2 (10.2) 30.7 (10.1) 27.8 (9.6) 27.4 (9.6) -0.19 (-2.30 to 1.92) 0.86
Unsaturated fat 306/332 323/341 9.2 (1.5) 9.4 (1.8) 9.1 (1.9) 9.1 (1.9) 1.46 (-0.41 to 3.33) 0.12
Self reported smoker 423/352 438/378 13.5 (57)§ 16.2 (71)§ 11.4 (40)§ 13.8 (52)§ 2.15 (0.65 to 8.39) 0.23
*See footnote to table 2 for relevant covariates.
†Scores range from zero upwards (no upper limit); score of ≥24 represents active, <24 represents insufficiently active.
‡Scores for dietary instrument for nutrition education range from 1-132 (fibre), 7-122 (fat), and 3-12 (unsaturated fat); higher scores represent more fibre, fat, or unsaturated fat.
§Percentage (number).
WHAT IS ALREADY KNOWN ON THIS TOPIC
Structured programmes of care in primary care lead to
improved provision of secondary prevention for patients
with established heart disease, but expected returns may
notbeachievedwhenbaselinemanagementlevelsarehigh
WHAT THIS STUDY ADDS
Within the current context of secondary cardiac prevention
provision in the United Kingdom and Ireland, further
improvements in risk factor management are difficult to
achieve
Current efforts in primary care should be maintained but
future focus may be at the population level and on those
patients with additional absolute risk or who are less likely
to be receiving optimal therapy
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